• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Radiol . Dynamic Evolution of COVID-19 on Chest Computed Tomography: Experience From Jiangsu Province of China

tetano

Editor, Senior Moderator
Eur Radiol


. 2020 Jun 10.
doi: 10.1007/s00330-020-06976-6. Online ahead of print.
Dynamic Evolution of COVID-19 on Chest Computed Tomography: Experience From Jiangsu Province of China


Yuan-Cheng Wang[SUP] 1 [/SUP], Huanyuan Luo[SUP] 2 [/SUP], Songqiao Liu[SUP] 3 [/SUP], Shan Huang[SUP] 1 [/SUP], Zhen Zhou[SUP] 4 [/SUP], Qian Yu[SUP] 1 [/SUP], Shijun Zhang[SUP] 1 [/SUP], Zhen Zhao[SUP] 1 [/SUP], Yizhou Yu[SUP] 5 [/SUP], Yi Yang[SUP] 3 [/SUP], Duolao Wang[SUP] 2 [/SUP], Shenghong Ju[SUP] 6 [/SUP]



Affiliations

Abstract

Objectives: To determine the patterns of chest computed tomography (CT) evolution according to disease severity in a large coronavirus disease 2019 (COVID-19) cohort in Jiangsu Province, China.
Methods: This retrospective cohort study was conducted from January 10, 2020, to February 18, 2020. All patients diagnosed with COVID-19 in Jiangsu Province were included, retrospectively. Quantitative CT measurements of pulmonary opacities including volume, density, and location were extracted by deep learning algorithm. Dynamic evolution of these measurements was investigated from symptom onset (day 1) to beyond day 15. Comparison was made between severity groups.
Results: A total of 484 patients (median age of 47 years, interquartile range 33-57) with 954 CT examinations were included, and each was assigned to one of the three groups: asymptomatic/mild (n = 63), moderate (n = 378), severe/critically ill (n = 43). Time series showed different evolution patterns of CT measurements in the groups. Following disease onset, posteroinferior subpleural area of the lung was the most common location for pulmonary opacities. Opacity volume continued to increase beyond 15 days in the severe/critically ill group, compared with peaking on days 13-15 in the moderate group. Asymptomatic/mild group had the lowest opacity volume which almost resolved after 15 days. The opacity density began to drop from day 10 to day 12 for moderately ill patients.
Conclusions: Volume, density, and location of the pulmonary opacity and their evolution on CT varied with disease severity in COVID-19. These findings are valuable in understanding the nature of the disease and monitoring the patient's condition during the course of illness.
Key points: • Volume, density, and location of the pulmonary opacity on CT change over time in COVID-19. • The evolution of CT appearance follows specific pattern, varying with disease severity.

Keywords: Coronavirus; Multidetector computed tomography; Viral pneumonia.
 
Back
Top Bottom